AMCP webinar that discussed AMCP’s 2021 Legislative and Regulatory Priority Issues and Strategies.
AMCP webinar that discussed AMCP’s 2021 Legislative and Regulatory Priority Issues and Strategies.
AMCP webinar that discussed AMCP’s 2021 Legislative and Regulatory Priority Issues and Strategies.
AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
AMCP supports efforts to encourage transparency within health care. This statement focuses on how transparency applies to the use of prescription information, drug costs and communication.
Opioid Legislation Passed by the U.S. House of Representatives in June 2018.
AMCP webinar that reviewed the provisions contained in the draft 2020 CMS Medicare Part D Call Letter that was released by the Centers for Medicare and Medicaid Services (CMS) on January 30, 2019.
AMCP webinar that reviewed the provisions contained in the draft 2020 CMS Medicare Part D Call Letter that was released by the Centers for Medicare and Medicaid Services (CMS) on January 30, 2019.
